CoChat
Sign Up
Cited by 158Chronic Obstructive Pulmonary Disease (COPD) ResearchPhysical Activity and HealthCardiovascular and exercise physiology

The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.

Improving physical activity in COPD: towards a new paradigm

Open access
Troosters, Thierry, van der Molen, Thys, Polkey, Michael, Rabinovich, Roberto A, Vogiatzis, Ioannis, Weisman, Idelle, Kulich, Karoly·2013·Respiratory Research
DOI 10.1186/1465-9921-14-115PMC PMC4176094
Open this paper in CoChat — free account

Abstract

Chronic obstructive pulmonary disease (COPD) is a debilitating disease affecting patients in daily life, both physically and emotionally. Symptoms such as dyspnea and muscle fatigue, lead to exercise intolerance, which, together with behavioral issues, trigger physical inactivity, a key feature of COPD. Physical inactivity is associated with adverse clinical outcomes, including hospitalization and all-cause mortality. Increasing activity levels is crucial for effective management strategies and could lead to improved long-term outcomes. In this review we summarize objective and subjective instruments for evaluating physical activity and focus on interventions such as pulmonary rehabilitation or bronchodilators aimed at increasing activity levels. To date, only limited evidence exists to support the effectiveness of these interventions. We suggest that a multimodal approach comprising pulmonary rehabilitation, pharmacotherapy, and counselling programs aimed at addressing emotional and behavioural aspects of COPD may be an effective way to increase physical activity and improve health status in the long term.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1465-9921-14-115

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The vicious cycle of inactivity and symptoms.
Figure 1 The vicious cycle of inactivity and symptoms.CC BY · PubMed Central
Figure 2 Regular physical activity reduces hospital admissions (upper panel A) and all-cause death (lower panel B) [50]. Kaplan-Meier curves according to level of regular physical activity during follow-up. Patients with COPD from the Copenhagen City Heart Study (n=2386), recruited from 1981 and followed to 2000. Reproduced from [50] with permission from BMJ Publishing Group Ltd.
Figure 2 Regular physical activity reduces hospital admissions (upper panel A) and all-cause death (lower panel B) [50]. Kaplan-Meier curves according to level of regular physical activity during follow-up. Patients with COPD from the Copenhagen City Heart Study (n=2386), recruited from 1981 and followed to 2000. Reproduced from [50] with permission from BMJ Publishing Group Ltd.CC BY · PubMed Central
Figure 3 Change in morning activities (absolute scores) over treatment period with budesonide/formoterol plus tiotropium versus placebo plus tiotropium [74]. CDLM: Capacity of Daily Living during the Morning questionnaire; dotted line represents budesonide/formoterol plus tiotropium; solid line represents placebo plus tiotropium; CDLM score at run-in budesonide/formoterol plus tiotropium: 4.09, placebo plus tiotropium: 4.13; †treatment comparison from randomization to first week of treatment; ‡treatment comparison from randomization to last week of treatment. Reprinted with permission of the American Thoracic Society. Copyright © 2013 American Thoracic Society. Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T, et al: Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients withchronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009, 180:741–750. Official journal of the American Thoracic Society.
Figure 3 Change in morning activities (absolute scores) over treatment period with budesonide/formoterol plus tiotropium versus placebo plus tiotropium [74]. CDLM: Capacity of Daily Living during the Morning questionnaire; dotted line represents budesonide/formoterol plus tiotropium; solid line represents placebo plus tiotropium; CDLM score at run-in budesonide/formoterol plus tiotropium: 4.09, placebo plus tiotropium: 4.13; †treatment comparison from randomization to first week of treatment; ‡treatment comparison from randomization to last week of treatment. Reprinted with permission of the American Thoracic Society. Copyright © 2013 American Thoracic Society. Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T, et al: Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients withchronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009, 180:741–750. Official journal of the American Thoracic Society.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

Sorted by citations

See all 158

Related

See all

Metadata

Authors
Troosters, T., van der Molen, T., Polkey, M., Rabinovich, R. A., Vogiatzis, I., Weisman, I., & Kulich, K.
Affiliations
  • Universitair Ziekenhuis Leuven (BE)
  • Royal Brompton Hospital (GB)
  • Centre for Inflammation Research (GB)
  • National and Kapodistrian University of Athens (GR)
Corresponding author
Troosters, Thierry
ORCID
Venue
Respiratory Research
Publisher
Springer Science and Business Media LLC
Published
2013
Volume
14
Issue
1
Pages
115
ISSN
1465-9921 (ISSN-L)
DOI
10.1186/1465-9921-14-115
PMC
PMC4176094
OpenAlex
W2111189556
Cited by
158
References
96
Citations by year
2026: 6 · 2025: 4 · 2024: 7 · 2023: 10 · 2022: 8 · 2021: 16 · 2020: 10 · 2019: 18 · 2018: 14 · 2017: 22 · 2016: 13 · 2015: 15 · 2014: 14 · 2013: 1
FWCI
2.23
Type
journal article
Language
en
Open access
Locations
  • Respiratory Research (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Lirias (submittedVersion, other-oa)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
Funders
  • Royal Brompton and Harefield NHS Foundation Trust
  • National Institute for Health and Care Research
  • Imperial College London
  • Novartis Pharma
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
  • Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
Keywords
chronic obstructive pulmonary disease, physical activity, physical inactivity, exercise intolerance, pulmonary rehabilitation, bronchodilators, physical activity measurement, multimodal intervention, behavioral interventions, health status
MeSH terms
Counseling, Drug Therapy, Health Status, Humans, Motor Activity, Exercise Tolerance, Pulmonary Disease, Chronic Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review